Liver fibrosis in adults with Fontan palliation: Do common screening studies predict disease severity?

Ofei SY; Gariepy C; Hanje J; Sisk T; Daniels CJ; Zaidi AN

doi:10.1016/j.ijcard.2014.12.031

Liver fibrosis in adults with Fontan palliation: Do common screening studies predict disease severity?

Ofei SY, Gariepy C, Hanje J, Sisk T, Daniels CJ …

Parole chiave — scelte dagli autori Congenital heart disease, FibroSure, Fontan, Hepatic fibrosis, Single ventricle

MeSH — NLM indexing Adolescent Adult Female Fontan Procedure / adverse effects Fontan Procedure / trends Humans Liver Cirrhosis / diagnosis Liver Cirrhosis / etiology Male Mass Screening / trends Predictive Value of Tests Severity of Illness Index Young Adult

Azioni del personale

Scarica PDF

I file sono per uso autorizzato solo nei canali dei partner BioPredictive.

Fibrotest Actitest Letter Independent Group United States

Autori (6)

Ofei SY — Nationwide Children's Hospital/The Ohio State University, Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, 700 Children's Drive, Columbus, OH 43205, USA. Electronic address: sylvia.ofei@nationwidechildrens.org.
Gariepy C — Nationwide Children's Hospital/The Ohio State University, Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, 700 Children's Drive, Columbus, OH 43205, USA. Electronic address: cheryl.gariepy@nationwidechildrens.org.
Hanje J — Wexner Medical Center/The Ohio State University, Department of Internal Medicine, Division of Gastroenterology, Hepatology and Nutrition, 370 West 9th Avenue, Columbus, OH 43210, USA. Electronic address: james.hanje@osumc.edu.
Sisk T — Nationwide Children's Hospital/The Ohio State University, The Columbus Ohio Adult Congenital Heart Disease Program (COACH), The Heart Center, Division of Pediatric Cardiology, 700 Children's Drive, Columbus, OH 43205, USA. Electronic address: tracey.sisk@nationwidechildrens.org.
Daniels CJ — Nationwide Children's Hospital/The Ohio State University, The Columbus Ohio Adult Congenital Heart Disease Program (COACH), The Heart Center, Division of Pediatric Cardiology, 700 Children's Drive, Columbus, OH 43205, USA; Wexner Medical Center/The Ohio State University, Department of Internal Medicine, Division of Cardiovascular Medicine, 370 West 9th Avenue, Columbus, OH 43210, USA. Electronic address: curt.daniels@nationwidechildrens.org.

Ofei SY — Nationwide Children's Hospital/The Ohio State University, Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, 700 Children's Drive, Columbus, OH 43205, USA. Electronic address: sylvia.ofei@nationwidechildrens.org.
Gariepy C — Nationwide Children's Hospital/The Ohio State University, Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, 700 Children's Drive, Columbus, OH 43205, USA. Electronic address: cheryl.gariepy@nationwidechildrens.org.
Hanje J — Wexner Medical Center/The Ohio State University, Department of Internal Medicine, Division of Gastroenterology, Hepatology and Nutrition, 370 West 9th Avenue, Columbus, OH 43210, USA. Electronic address: james.hanje@osumc.edu.
Sisk T — Nationwide Children's Hospital/The Ohio State University, The Columbus Ohio Adult Congenital Heart Disease Program (COACH), The Heart Center, Division of Pediatric Cardiology, 700 Children's Drive, Columbus, OH 43205, USA. Electronic address: tracey.sisk@nationwidechildrens.org.
Daniels CJ — Nationwide Children's Hospital/The Ohio State University, The Columbus Ohio Adult Congenital Heart Disease Program (COACH), The Heart Center, Division of Pediatric Cardiology, 700 Children's Drive, Columbus, OH 43205, USA; Wexner Medical Center/The Ohio State University, Department of Internal Medicine, Division of Cardiovascular Medicine, 370 West 9th Avenue, Columbus, OH 43210, USA. Electronic address: curt.daniels@nationwidechildrens.org.
Zaidi AN — Nationwide Children's Hospital/The Ohio State University, The Columbus Ohio Adult Congenital Heart Disease Program (COACH), The Heart Center, Division of Pediatric Cardiology, 700 Children's Drive, Columbus, OH 43205, USA; Wexner Medical Center/The Ohio State University, Department of Internal Medicine, Division of Cardiovascular Medicine, 370 West 9th Avenue, Columbus, OH 43210, USA. Electronic address: azaidi@montefiore.org.

Citazione

Ofei SY, Gariepy C, Hanje J, Sisk T, Daniels CJ, Zaidi AN. Liver fibrosis in adults with Fontan palliation: Do common screening studies predict disease severity?. Int J Cardiol. 2015;181:174-5. doi:10.1016/j.ijcard.2014.12.031.

Identificatori

DOI: 10.1016/j.ijcard.2014.12.031
PMID: 25528305

Test

Malattie del fegato

Lesioni epatiche

Confronti

Argomenti

Regione

Carrello

Il carrello è vuoto.

Sfoglia le pubblicazioni e usa Aggiungi al carrello su qualsiasi pagina di dettaglio per creare un archivio ZIP da inviare ai clienti.

Sfoglia le pubblicazioni

Liver fibrosis in adults with Fontan palliation: Do common screening studies predict disease severity?

Altro sullo stesso argomento

An Invisible Early Steatosis Phenotype Defined for a Large Population-Based Cohort.

Diagnostic performance of FibroTest-ActiTest, transient elastography, and the fibrosis-4 index in patients with autoimmune hepatitis using histological reference.

Metabolic dysfunction-associated steatotic liver disease (MASLD) biomarkers and progression of lower limb arterial calcification in patients with type 2 diabetes: a prospective cohort study.

Noninvasive Assessment of Liver Fibrosis.

Screening for Metabolic Dysfunction-Associated Steatotic Liver Disease-Related Advanced Fibrosis in Diabetology: A Prospective Multicenter Study.

Toward non-invasive assessment strategies in autoimmune hepatitis.